Aim: To investigate whether aristolochic acid (AA) induced the apoptosis of human umbilical vein endothelial cells (HUVECs) in vitro and the underlying mechanism. Methods: HUVECs were treated with AA (5, 10 or 20 μg/mL) for 12, 24 and 48 h. Cell viabilities were determined with MTT assay. Hoechst 33258 staining and flow cytometry were used to examine the apoptosis of HUVECs. Western blotting was used to evaluate Akt phosphorylation. Bcl-2 and Bax levels were measured using Western blotting and RT-PCR assays. Results: Treatment of HUVECs with AA significantly decreased the cell viabilities in dose-and time-dependent manners. Morphological changes of apoptosis were observed in AA-treated cells. AA inhibited Akt activation, which was attenuated by pretreatment of the cells with LY294002 (20 μmol/L) or wortmannin (50 nmol/L). Furthermore, AA reduced Bcl-2 levels and increased Bax levels. Conclusion: AA induces apoptosis of HUVECs in vitro via the PI3K/Akt signaling pathway and by modulating the ratio Bcl-2 and Bax.
Introduction
Aristolochic acid (AA), an active component of the Chinese herbal medicines derived from the Aristolochia species, has been implicated in AA nephropathy (AAN), which is a progressive tubulointerstitial nephropathy. Studies indicated that blood vessel impairment was present in AAN [1, 2] , and could be one of the causes for the progressive tubulointerstitial damage. In renal biopsy samples of AAN patients, the abnormal ultrastructure of endothelial cells within the microvasculature and marked injury of peritubular capillaries were accompanied by low vascular endothelial growth factor (VEGF) levels [3] in tubular cells. It was further indicated that endothelial injury was related to the deterioration of renal function in AAN [4] . It is well known that VEGF is an important endogenous proangiogenic molecule, which can induce angiogenesis by acting directly on the endothelium in vivo [5] . VEGF potently blocks the execution of apoptosis of endothelial cells [6] [7] [8] . Withdrawal of VEGF by targeted inactivation of the VEGF gene results in massive endothelial cell apoptosis [9, 10] . Apoptotic endothelial cell death may critically disturb the integrity of the endothelial monolayer and thereby contribute to vascular injury. VEGF could activate the survival-promoting PI3K/Akt pathway [6, 11, 12] . Activation of the serine/threonine kinase Akt in turn stimulates the phosphorylation of pro-apoptotic proteins such as Bad and consequently inhibits apoptosis execution [13] . Moreover, Akt activates the endothelial nitric oxide (NO) synthase, leading to enhanced synthesis of NO [14, 15] , which promotes endothelial cell survival by inhibiting the cysteine protease activity of caspases via S-nitrosylation of the reactive cysteine residue [16] . In addition, recent studies have demonstrated that a PI3K/Akt-dependent enhancement in the expression of the anti-apoptotic protein survivin is important for the apoptosis protective effects of angiogenic factors [17] [18] [19] . Finally, VEGF mediates the upregulation of the anti-apoptotic protein Bcl-2 [20] . Thus, the impairment of the intracellular survival signals activated by VEGF has deleterious effects on vessel development.
These data suggests possible inhibitory effect of AA on vessel development indirectly. The objective of the current study was to investigate the direct effects of AA on vascular endothelial cells in vitro and to explore the underlying 
Materials and methods
Cell culture and drug treatment Human umbilical vein endothelial cells (HUVECs) (American Type Culture Collection, Rockville, MD, USA) were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, USA) supplemented with 10% fetal bovine serum (Haoyang Biotech Co, China), 100 U/mL penicillin and 100 μg/mL streptomycin at 37 °C in a humidified incubator containing 5% CO 2 and 95% air. For drug treatment, HUVECs were incubated with 5, 10 or 20 μg/mL AA (Sigma, USA) for 12, 24, or 48 h. HUVECs were also pretreated with specific PI3K inhibitor, LY294002 at 20 μmol/L or wortmannin at 50 nmol/L (Beyotime Institute of Biotechnology, China) for 30 min prior to treatment with 10 μg/mL AA.
Cell viability assays
Cell viability was assessed by the tetrazolium-based semiautomated colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay (Sigma, USA). Cells were seeded at a density of 1×10 4 cells/well in 96-well plates. After 24 h incubation, cells were treated with AA at 5, 10, or 20 μg/mL for 12, 24, or 48 h. MTT assays were performed as instructed by the manufacturer and absorbance was read at 490 nm using a microplate reader (Sunrise RC, Tecan, Switzerland). Relative cell viability was expressed as the percentage of the control.
Hoechst 33258 staining assays Morphological evaluation of apoptosis was performed using Hoechst 33258 (Beyotime Institute of Biotechnology) according to the manufacturer's instructions. Cells were fixed with 4% paraformaldehyde for 10 min at 4 °C and stained with Hoechst 33258 for 10 min at room temperature in the dark. Nuclear morphology was then examined under a fluorescent microscope (Leica, Wetzlar, Germany).
Flow cytometric studies
Flow cytometry using annexin V-FITC and propidium iodide (PI) double staining was performed using the annexin V-FITC apoptosis detection kit (Jinmei Biotech Co, China). Cells were harvested, washed twice with cold PBS and resuspended at 1×10 6 cells/mL in 100 μL binding buffer (10 mmol/L Hepes/ NaOH, pH 7.4, 140 mmol/L NaCl and 2.5 mmol/L CaCl 2 ). Annexin V-FITC (5 μL) and 10 μL PI (20 μg/mL) were added to the cell suspension (100 μL) in the dark followed by incubation at room temperature for 15 min in the dark and then mixed with 400 μL binding buffer, and flow cytometry (FACScalibur, Becton-Dickison, USA) was carried out within 1 h. Data analysis was performed using the Modifit Flow Cytometry Software.
Western blotting studies HUVECs were lysed using RIPA lysis buffer containing 50 mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 1% sodium deoxycholate, 1% NP-40, 1 mmol/L phenylmethylsulfonyl fluoride and 1 mmol/L EDTA. Protein concentration was determined by Bradford assay (Bio-Rad, USA). Samples containing 10 μg total protein were resolved by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and then electrophoretically transferred to a polyvinylidene difluoride membrane. The membranes were incubated with 5% non-fat dried milk in TBS-Tween 20 (10 mmol/L Tris-buffered saline with 0.1% Tween 20) at room temperature for 1 h, and then incubated with anti-phospho-S473 Akt polyclonal antibody, anti-Bcl-2 polyclonal antibody, or anti-Bax polyclonal antibody (ABZOOM, USA) overnight at 4 °C. After incubation with goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology, USA) for 2 h at room temperature, the immune complexes were visualized by enhanced chemiluminescence methods. Band intensity was analyzed by the Scion Image software and compared with the internal standard β-actin.
Caspase-3 activity assay Caspase-3 activity was assessed via a colorimetric assay according to the manufacturer's protocols (BD Biosciences, USA). After treatment, the cells were collected by trypsinization and washed twice with ice-cold PBS followed by centrifugation. The cellular pellet was resuspended in cell lysis buffer and incubated on ice for 10 min. Lysates were centrifuged for 1 min at 10 000 revolutions per minute, and the supernatants were assayed for caspase-3 activity in reaction buffer/DTT Mix. After addition of caspase-3 substrate (Ac-DEVD-pNA), samples were incubated for 4 h at 37 °C and caspase-3 activity (pNA) was measured by a spectrofluorometer (Bio-Rad, USA) at 405 nm. Caspase-3 activity was expressed as the fold of the control.
RT-PCR analysis
The cells were harvested after AA treatment and washed twice in cold PBS. Total RNA was extracted using the TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions and RNA was dissolved in RNase-free water. The concentration and purity of RNA were determined using a UV300 spectrophotometer at 260 nm and 280 nm. Complementary DNA (cDNA) was synthesized in a volume of 20 μL with a cDNA synthesis kit (Takara Biotechnology, China) according to the manufacturer's protocol. The obtained cDNA was amplified by PCR. The sequences of primers used were: 5'-TAATTGCCAAGCACCGCTTC-3' (sense) and 5'-CCAGGTATGCATCATGTGAG-3' (antisense) for Bcl-2; 5'-AGTAACATGGAGCTGCAGAG-3' (sense) and 5'-ACAAA-GATGGTCACGGTCTG-3' (antisense) for Bax; 5'-TCTACAAT-GAGCTGCGTGTG-3' (sense) and 5'-GGATGTCCACGTCA-CACTTC-3' (antisense) for β-actin. The PCR conditions were: 95 °C for 2 min; 30 cycles of 95 °C for 45 s, 55 °C for 45 s, and 72 °C for 1 min, followed by a final extension at 72 °C for 7 min. The amplified PCR products were separated by 1.5% agarose (Amersco, USA) gel electrophoresis and visualized by ethidium bromide staining. Bcl-2 and Bax levels were normal- 
Statistical analysis
The data were expressed as mean±SD. All data were analyzed using the SPSS13.0 program (SPSS Inc, Chicago, IL, USA), and statistical differences were determined by paired sample t-test or one way ANOVA-test (SNK post test). P<0.05 was considered statistically significant.
Results

AA reduces viabilities
Prior to the investigation of the toxic effect of AA on HUVECs, we sought to understand the effect of AA on cell viability by MTT assay. The cells were exposed to 5, 10, or 20 μg/mL AA for 12, 24, and 48 h, respectively. As shown in Figure 1 , AA significantly inhibited cell viability compared to controls in a dose-and time-dependent manner.
AA induces apoptosis of HUVECs
To further examine morphological changes in response to AA, both control and AA-treated cells were stained with fluorescent dye Hoechst 33528 and visualized under a fluorescent microscope. Figure 2A shows the results of Hoechst 33528 staining for AA treated-cells at the concentrations of 5, 10, or 20 μg/mL for 24 h. The untreated cells stained uniformly blue. At 5 μg/mL AA, cells began to display apoptotic morphology. Fluorescence was detected in the nuclear region of HUVECs, indicating the presence of DNA fragmentation. At 10 and 20 μg/mL of AA, nuclear condensation and fragmentation became more apparent. The chromatin was condensed into lumps, exhibiting punctuated morphology typical of apoptotic cells. These observations provided evidence that AA induced apoptosis in HUVECs.
To gain further insight into the pro-apoptotic effect of AA on HUVECs quantitatively, we examined the percentage of apoptotic cells exposed to AA by flow cytometry using annexin V-FITC and PI staining. The percentage of apoptotic cells was 6.64%±0.78% in the control. After treatment with 5, 10, or 20 μg/mL AA for 24 h, the percentage of apoptotic cells Figure 2B ).
AA suppresses the activation of Akt
To explore the possible mechanism for the pro-apoptotic effect of AA, we investigated the effect of AA on Akt activation. Western blotting studies using anti-phospho-S473 Akt antibodies analysis showed that AA (10 μg/mL) inhibited the activation of Akt in HUVECs after 15, 30, 60, or 120 min of drug exposure, with the minimum activation at approximately 30 min ( Figure 3A ). In addition, as indicated in Figure 3B , AA also inhibited Akt activation at 30 min in a dose-dependent manner at doses ranging from 5 to 20 μg/mL. We further tested the effect of PI3K specific inhibitors LY294002 or wortmannin on AA-induced Akt inactivation in HUVECs. The results showed that pretreatment with LY294002 or wortmannin for 30 min prior to stimulation with AA (10 μg/mL) for 30 min attenuated the inhibitory effect of AA on Akt activation, suggesting that the effect of AA on Akt inactivation was mediated through the PI3K/Akt signaling pathway ( Figure 3C ).
AA activates caspase-3 via the PI3K/Akt pathway
We further measured caspase-3 activity of HUVECs exposed to AA. As shown in Figure 4 , a marked increase in caspase-3 activity was observed in cells incubated with 10 μg/mL AA for 24 h (1.645±0.076 vs 1.000±0.037 for the control, P<0.01), and the increase was attenuated when LY294002 (1.263±0.045 vs 10 μg/mL AA, P<0.01) or wortmannin (1.205±0.047 vs 10 μg/mL AA, P<0.01) was added before AA treatment, suggesting that AA induced apoptosis of HUVECs through the PI3K/ Akt signaling pathway.
AA down-regulates the expression of Bcl-2 To further explore the possible mechanism of the pro-apoptotic effect of AA, we investigated the effect of AA on the expression of anti-apoptotic gene Bcl-2 in HUVECs. Exposure to 5, 10 or 20 μg/mL AA for 24 h decreased the level of Bcl-2 protein expression in HUVECs to 0.57±0.032, 0.44±0.028 or 0.35±0.031, respectively, which was significantly lower than that of controls (0.65±0.026) (P<0.05 or P<0.01) ( Figure 5A ). We further detected the effect of AA on the expression of Bcl-2 mRNA. Treatment with various concentrations of AA (5, 10, 20 μg/mL) for 24 h significantly reduced the expressions of Bcl-2 mRNA (0.58±0.037, 0.42±0.03 and 0.36±0.024, respectively) compared with the controls (0.66±0.022) (P<0.05 or P<0.01) ( Figure 5B ).
AA up-regulates the expression of Bax
The Bax/Bcl-2 family are important apoptotic regulating factors in the intrinsic apoptotic pathway and the ratio of Bax/ Bcl-2 is critical to cell survival. We next determined the expression of Bax protein by Western blotting. Following a 24-h treatment with 5, 10, or 20 μg/mL AA, we detected increased levels of the Bax protein (0.38±0.022, 0.56±0.032, and 0.45±0.028, respectively) compared with the control (0.32±0.027). There was a significant difference in Bax expression levels between AA-induced cells and the control (P<0.05 or P<0.01, Figure 6A ). This study also detected the effect of AA on the expression of Bax mRNA. The results showed that the expression of Bax mRNA stimulated by AA (5, 10, or 20 μg/mL) for 24 h was significantly increased (0.41±0.031, 0.55±0.038 and 0.48±0.023, respectively) compared with that of the control (0.35±0.024) Figure 6B ).
Discussion
Many Chinese medicinal herbs contain AA, which has been extensively used to treat digestive and urogenital system diseases. AA reacts with cellular proteins and DNA, resulting in multiple forms of toxicity [21] . AAN is a progressive tubulointerstitial renal disease caused by AA intake. Progressive loss of peritubular capillaries was demonstrated in AAN model, which was associated with decreased expression of VEGF [22] . Recently, VEGF has emerged as a crucial element in vascular homeostasis. VEGF is an angiogenic factor and an endothelial cell survival factor [6] . Withdrawal of VEGF by targeted inactivation of the VEGF gene results in massive endothelial cell apoptosis [9, 10] . Vascular endothelial cells form the inner lining of all blood vessels and play an important role in regulating vascular function. Since the vascular endothelium is involved in various physiological processes, endothelial cell apoptosis (and dysfunction) may constitute an initial step in a variety of pathological situations such as atherosclerosis and hypertension. The data document the inhibitory effect of AA on vessel development indirectly. The direct effects of AA on vascular endothelial cells are unclear. Our study showed that AA could induce endothelial cell apoptosis and increase activation of caspase-3. Moreover, we determined the signaling pathway involved in the pro-apoptotic effect of AA: we found that exposure of cells to AA or the PI3K inhibitor (wortmannin or LY294002) alone could likewise cause inactivation of Akt, and pretreatment with PI3K inhibitor (LY294002 or wortmannin) to block primarily the PI3K/Akt pathway before AA treatment could attenuate the effect of AA on the activation of Akt and [23] . The full activation of Akt requires phosphorylation at both Thr 308 and Ser 473. VEGF inhibits endothelial cell apoptosis through activating the PI3K/Akt signal pathway [6, 11, 12] . In endothelial cells, Akt activation has been reported to promote cell survival [15] . LY294002 and wortmannin are two broad-specific inhibitors of P13K. They can completely inhibit PI3K activity, thereby blocking the activation of Akt. Our study directly observed Akt (Ser 473) phosphorylation after treatment with AA. The results of our study indicated that AA has a pro-apoptotic effect on endothelial cells, and, at least partly, via blocking PI3K/Akt pathway.
Moreover, there was evidence that VEGF prevents the apoptosis of endothelial cells via up-regulating the expression of anti-apoptotic gene Bcl-2 [20] . The Bcl-2 family play a crucial role in the control of apoptosis. The Bcl-2 family of proteins contain both inhibitors (Bcl-2, Bcl-x L ) and inducers (Bcl-x S , Bax, Bid, Bad, Bak) of apoptosis. The balance between antiapoptotic and pro-apoptotic Bcl-2 family members is critical to determining if a cell undergoes apoptosis. In the present study, we observed that AA could reduce Bcl-2 expression and improve Bax expression. The level of Bax protein expression was significantly decreased in cells incubated with 20 μg/mL AA; the explanation could be the massive necrosis.
Our study demonstrates that AA can cause the apoptosis of endothelial cells. This apoptosis may be related to the inhibition of PI3K/Akt signaling pathway and modulating the ratio of Bcl-2 and Bax.
